AZN vs KOPN · P/E 28, $288.38B cap vs P/E 486, rev $1.7M
AstraZeneca PLC (AZN) versus Kopin Corporation (KOPN) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Kopin Corporation (KOPN) is a electronic components company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported KOPN revenue for 2026-06-27 was $1.7M. Net income was -$2.9M. KOPN currently screens at market cap $900.6M and trailing P/E 486.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. KOPN currently screens at market cap $900.6M and trailing P/E 486.0.
Not investment advice. Open the AZN and KOPN stock pages for the full models.
Not investment advice.